Daryl Kreml
Head of Ethics & Compliance Takeda Oncology
Seminars
Wednesday 5th August 2026
Enhancing Compliance Governance of Functional Roles & Responsibilities to Reduce Enforcement Risk
2:15 pm
- Minimize enforcement and promotional risk through well-defined functional roles, decision rights, and compliance program design that clearly assigns activities across medical, commercial, HEOR, payer, research, and field teams
- Clarify high-risk cross-functional interfaces, including medical-commercial boundaries, payer engagement, and research interactions, to prevent blurred ownership and reduce OPDP and regulatory exposure
- Implement stage-appropriate governance structures that scale from development through commercialization, enabling faster decision-making while maintaining compliance integrity and defensibility
Thursday 6th August 2026
Panel Discussion: Practical Considerations in Cross-Border Transactions Amid Geopolitical & Market Uncertainty
2:10 pm
- Evaluate how public policy shifts, geopolitical uncertainty, and changes across the international biopharma landscape are reshaping transaction structures, negotiations, and deal execution
- Future-proof cross-border transactions by building flexibility into deal terms, governance frameworks, and risk allocation mechanisms amid continued market uncertainty
- Strengthen diligence and decision-making when evaluating international assets, partners, and opportunities while preparing for emerging trends in cross-border dealmaking
